Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Exocyst complex component 8 pseudogene" is a non-functional genomic DNA sequence derived from the exocyst complex component 8 (EXOC8) gene. Pseudogenes such as this are typically the result of gene duplication or retrotransposition events followed by mutations that result in loss of protein-coding function. Unlike its parental gene (EXOC8), which encodes a key protein of the exocyst complex involved in vesicular trafficking and exocytosis, this pseudogene does not produce a functional protein and is not known to have any direct biological activity, therapeutic relevance, or role in disease. In general, most pseudogenes are considered "genomic fossils," although a minority may acquire regulatory functions; as of now, there is no direct evidence that the exocyst complex component 8 pseudogene has such a function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Exocyst complex component 8 pseudogene.